Package 60219-2090-4
Brand: famotidine
Generic: famotidinePackage Facts
Identity
Package NDC
60219-2090-4
Digits Only
6021920904
Product NDC
60219-2090
Description
50 mL in 1 BOTTLE (60219-2090-4)
Marketing
Marketing Status
Brand
famotidine
Generic
famotidine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ec5e06f5-b43c-4f18-848f-590cb7948210", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0360219209046"], "unii": ["5QZO15J2Z8"], "rxcui": ["310274"], "spl_set_id": ["443e8ea6-7d51-4db7-8f0b-7a854d45bf23"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 BOTTLE (60219-2090-4)", "package_ndc": "60219-2090-4", "marketing_start_date": "20240513"}], "brand_name": "Famotidine", "product_id": "60219-2090_ec5e06f5-b43c-4f18-848f-590cb7948210", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "60219-2090", "generic_name": "Famotidine", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "40 mg/5mL"}], "application_number": "ANDA216427", "marketing_category": "ANDA", "marketing_start_date": "20240513", "listing_expiration_date": "20261231"}